Published in Pharmacology on January 01, 1975
In vivo histamine optical nanosensors. Sensors (Basel) (2012) 0.76
[Effectiveness of fixed analgesic combinations exemplified by thomapyrin]. Wien Klin Wochenschr (1996) 2.03
Transport of nucleoside drugs in animal cells. Pharmacol Ther (1981) 1.44
[The basics of catecholamine therapy. 2. A guide to clinical use]. Anasthesiol Intensivmed Notfallmed Schmerzther (2000) 1.43
Specificity of adenosine uptake into the heart and inhibition by dipyridamole. Eur J Pharmacol (1970) 1.42
Different sites of adenosine formation in the heart. Am J Physiol (1981) 1.39
Stimulation of the mitogen-activated protein kinase via the A2A-adenosine receptor in primary human endothelial cells. J Biol Chem (1997) 1.30
Urapidil and some analogues with hypotensive properties show high affinities for 5-hydroxytryptamine (5-HT) binding sites of the 5-HT1A subtype and for alpha 1-adrenoceptor binding sites. Naunyn Schmiedebergs Arch Pharmacol (1987) 1.23
Inhibition of adenosine uptake in human erythrocytes by adenosine-5'-carboxamides, xylosyladenine, dipyridamole, hexobendine, and p-nitrobenzylthioguanosine. Biochem Pharmacol (1978) 1.18
Species differences in action and elimination of adenosine after dipyridamole and hexobendine. Eur J Pharmacol (1971) 1.17
Role of S-adenosylhomocysteine hydrolase in adenosine metabolism in mammalian heart. Biochem J (1981) 1.14
Absence of binding sites for the transport inhibitor nitrobenzylthioinosine on nucleoside transport-deficient mouse lymphoma cells. Biochim Biophys Acta (1981) 1.14
Pelvic urine composition as a determinant of inner medullary solute concentration and urine osmolarity. Pflugers Arch (1972) 1.13
Functional identification of adenylate cyclase-coupled adenosine receptors in rat brain microvessels. Eur J Pharmacol (1982) 1.09
Stimulation of human umbilical vein endothelial cell proliferation by A2-adenosine and beta 2-adrenoceptors. Br J Pharmacol (1995) 1.09
Functional expression of the human serotonin 5-HT1A receptor in Escherichia coli. Ligand binding properties and interaction with recombinant G protein alpha-subunits. J Biol Chem (1992) 1.08
The effects of starvation and of acute and chronic alloxan diabetes on myocardial substrate levels and on liver glycogen in the rat in vivo. Eur J Biochem (1967) 1.07
Adenosine uptake by erythrocytes of man, rat and guinea-pig and its inhibition by hexobendine and dipyridamole. Biochem Pharmacol (1975) 1.04
Perioperative risk of bradyarrhythmias in patients with asymptomatic chronic bifascicular block or left bundle branch block: does an additional first-degree atrioventricular block make any difference? Anesthesiology (1998) 1.02
Adenosine receptor agonists: binding and adenylate cyclase stimulation in rat liver plasma membranes. Naunyn Schmiedebergs Arch Pharmacol (1982) 1.00
[Effect of hexabendin on oxygen consumption, energetics and substrate metabolism of the heart. II. Studies with intravenously administered single doses]. Arzneimittelforschung (1966) 0.99
Expression of two human beta-adrenergic receptors in Escherichia coli: functional interaction with two forms of the stimulatory G protein. Proc Natl Acad Sci U S A (1991) 0.98
Perioperative transcutaneous pacemaker in patients with chronic bifascicular block or left bundle branch block and additional first-degree atrioventricular block. Acta Anaesthesiol Scand (1999) 0.98
Coronary dilatory action of adenosine analogues: a comparative study. Arch Int Pharmacodyn Ther (1977) 0.96
The role of a low beta 1-adrenoceptor selectivity of [3H]CGP-12177 for resolving subtype-selectivity of competitive ligands. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.94
Interactions of the bovine brain A1-adenosine receptor with recombinant G protein alpha-subunits. Selectivity for rGi alpha-3. J Biol Chem (1991) 0.94
Calcium gradient-dependent and calcium gradient-independent phosphorylation of sarcoplasmic reticulum by orthophosphate. The role of magnesium. Eur J Biochem (1978) 0.93
Interactions of purified bovine brain A1-adenosine receptors with G-proteins. Reciprocal modulation of agonist and antagonist binding. Biochem J (1991) 0.93
Use of multi-plane transoesophageal echocardiography in visualization of the main hepatic veins and acquisition of Doppler sonography curves. Comparison with the transabdominal approach. Br J Anaesth (2001) 0.92
Effects of etomidate, midazolam, and thiopental on median nerve somatosensory evoked potentials and the additive effects of fentanyl and nitrous oxide. Anesth Analg (1988) 0.92
Manipulation of toxicity and tissue distribution of tubercidin in mice by nitrobenzylthioinosine 5'-monophosphate. Biochem Pharmacol (1982) 0.92
[Inhibition of adenosine uptake and stimulation of its effect on isolated hearts of warm-blooded animals by coronary active substances]. Arzneimittelforschung (1969) 0.91
Differences in the GTP-regulation of membrane-bound and solubilized A1-adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol (1989) 0.91
[Effect of Aminorex (Manocil) on hemodynamics of the pulmonary and systemic circulation during intravenous administration in dogs]. Naunyn Schmiedebergs Arch Pharmakol (1969) 0.90
Evidence against adenylate cyclase-coupled adenosine receptors in the guinea pig heart. Eur J Pharmacol (1981) 0.88
Ionized and bound calcium inside isolated sarcoplasmic reticulum of skeletal muscle and its significance in phosphorylation of adenosine triphosphatase by orthophosphate. Eur J Biochem (1979) 0.87
Sensitization of dopamine-stimulated adenylyl cyclase in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated rhesus monkeys and patients with idiopathic Parkinson's disease. J Neurochem (1992) 0.87
Glomeruli and microvessels of the rabbit kidney contain both A1- and A2-adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.87
Enhancement of the coronary dilator effect of intravenous and intracoronary administered adenosine by hexobendine in dogs. Eur J Pharmacol (1971) 0.87
In vitro and in vivo uroselectivity of B8805-033, an antagonist with high affinity at prostatic alpha1A- vs. alpha1B- and alpha1D-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol (2001) 0.86
[Effect of hexobendine on the arterial and coronary venous CO2 tension and hydrogen-ion concentration in dogs. Contribution on the theory of the mechanism of action of coronary dilator agents]. Arzneimittelforschung (1968) 0.86
P2-, but not P1-purinoceptors mediate formation of 1, 4, 5-inositol trisphosphate and its metabolites via a pertussis toxin-insensitive pathway in the rat renal cortex. Br J Pharmacol (1990) 0.86
The effects of adenosine on coronary conductance, cardiac dynamics and myocardial metabolism of the isolated perfused cat heart. Pharmacology (1974) 0.85
The effects of an intracoronary infusion of adenosine on cardiac performance, blood supply and on myocardial metabolism in dogs. Pflugers Arch (1970) 0.85
Interaction of urapidil with brain serotonin-1A receptors increases the blood pressure reduction due to peripheral alpha-adrenoceptor inhibition. J Hypertens Suppl (1988) 0.84
Vasodilatation elicited by 5-HT1A receptor agonists in constant-pressure-perfused rat kidney is mediated by blockade of alpha 1A-adrenoceptors. Eur J Pharmacol (1991) 0.84
The cyclin-dependent kinase inhibitor p21cip1 mediates the growth inhibitory effect of phorbol esters in human venous endothelial cells. J Biol Chem (1997) 0.84
Effect of aminophylline on coronary reactive hyperaemia following brief and long occlusion periods. Cardiovasc Res (1977) 0.84
The effects of NECA (adenosine-5'N-ethylcarboxamide) and of adenosine on glucagon and insulin release from the in situ isolated blood-perfused pancreas in anesthetized dogs. Naunyn Schmiedebergs Arch Pharmacol (1982) 0.83
Effects of exercise on circulating vascular adhesion molecules in healthy men. Immunobiology (1997) 0.83
Cardiac ventricular beta 2-adrenoceptors in guinea-pigs and rats are localized on the coronary endothelium. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.83
Evidence for glucagon-releasing activity of vasoactive adenosine analogues in the conscious dog. Naunyn Schmiedebergs Arch Pharmacol (1978) 0.83
Pulmonary and systemic circulatory effects and -adrenergic selectivity of hexoprenaline, salbutamol, oxyfedrine, and isoproterenol. Eur J Pharmacol (1971) 0.83
Characterization of angiotensin-II effects on cerebral and ocular circulation by noninvasive methods. Br J Clin Pharmacol (1997) 0.82
A different desensitization pattern of cardiac beta-adrenoceptor subtypes by prolonged in vivo infusion of isoprenaline. J Cardiovasc Pharmacol (1989) 0.82
pH and temperature dependence of adenosine uptake in human erythrocytes. Eur J Pharmacol (1978) 0.82
The effects of intra-arterial adenosine infusion on substrate levels and blood flow in skeletal muscle of the dog. Naunyn Schmiedebergs Arch Pharmacol (1973) 0.82
Role of nitric oxide in hemostatic system activation in vivo in humans. Arterioscler Thromb Vasc Biol (1995) 0.82
Formation of magnesium-phosphoenzyme and magnesium-calcium-phosphoenzyme in the phosphorylation of adenosine triphosphatase by orthophosphate in sarcoplasmic reticulum. Models of a reaction sequence. Eur J Biochem (1981) 0.82
Phosphorylated adenosine derivatives as low-affinity adenosine-receptor agonists. Methodological implications for the adenylate cyclase assay. Biochem J (1984) 0.82
Usefulness of chromogranin A as a marker for detection of relapses of carcinoid tumours. Clin Chem Lab Med (1998) 0.82
Effects of ischemia on the canine myocardial beta-adrenoceptor-linked adenylate cyclase system. J Cardiovasc Pharmacol (1987) 0.81
Regional and laminar distributions of alpha 1-adrenoceptors and their subtypes in human and rat hippocampus. Neuroscience (1991) 0.81
Relaxation of coronary artery strips by adenosine and acidosis. Eur J Pharmacol (1977) 0.81
High-glucose incubation of human umbilical-vein endothelial cells does not alter expression and function either of G-protein alpha-subunits or of endothelial NO synthase. Biochem J (1996) 0.81
2',3'-Dialdehyde GTP as an irreversible G protein antagonist. Disruption and reconstitution of G protein-mediated signal transduction in cells and cell membranes. J Biol Chem (1994) 0.81
[Effect of hexobendine on the coronary efficacy of generalized hypoxia as well as of i.cor. and i.v. single injections of adenosine in dogs]. Arzneimittelforschung (1973) 0.81
Biotransformation of urapidil: metabolites in serum and urine and their biological activity in vitro and in vivo. Arch Int Pharmacodyn Ther (1984) 0.81
Function of the autonomic nervous system in young, untreated hypertensive patients. Int J Cardiol (1986) 0.80
Evaluation of prostaglandin-receptors in human and rat liver: interspecies differences at the prostaglandin receptor-level. Prostaglandins (1988) 0.80
Influence of aminophylline or beta-adrenoceptor blockade on glucagon release by a vasoactive adenosine analogue. Arch Int Pharmacodyn Ther (1978) 0.80
Effect of a 5'-substituted adenosine analogue (744c96) on insulin and glucagon release in isolated rat islets of Langerhans. Arch Int Pharmacodyn Ther (1979) 0.80
A comparison of the effects of hexobendine with those of anoxia on the concentration of myocardial metabolites in vivo. Eur J Pharmacol (1967) 0.80
Effects of the acylcarnitine-transferase blocking agent sodium 2[5-(4-chlorophenyl)-pentyl]-oxirane-2-carboxylate (POCA) on metabolism and regional function in the underperfused canine myocardium. J Cardiovasc Pharmacol (1985) 0.80
The myocardial oxaloacetate level in normal and chronic alloxan-diabetic rats in vivo. J Mol Cell Cardiol (1972) 0.79
Age-related changes in vascular reactivity in genetically diabetic rats. Pharmacology (1995) 0.79
Modification by nitrobenzylthioinosine-5'-monophosphate of pseudoisocytidine pharmacokinetics in mice and rats through inhibition of membrane transport. Cancer Treat Rep (1983) 0.79
Influence of hexobendine, dipyridamole, dilazep, lidoflazine, inosine and purine riboside on adenosine uptake by the isolated epithelium of guinea pig jejunum. Pharmacology (1978) 0.79
Pheochromocytoma of the urinary bladder--a case report and review of the literature. Urol Int (1984) 0.79
Alterations of the glomerular beta-adrenoceptor-linked adenylate cyclase system in perinephritis hypertension. J Cardiovasc Pharmacol (1986) 0.79
Binding of [3H]ouabain to endothelial cells derived from various vascular beds. Basic Res Cardiol (1988) 0.79
[Memantine and neurogenic bladder disorders within the bounds of spastic conditions]. Arzneimittelforschung (1982) 0.79
Influence of angiotensin II on circulating adhesion molecules and blood leukocyte count in vivo. Can J Physiol Pharmacol (1996) 0.79
The Erlanger Microlightguide Photometer: a new concept for monitoring intracapillary oxygen supply of tissue--first results and a review of the physiological basis. J Clin Monit (1996) 0.78
Does transurethral resection of prostatic carcinoma promote tumor spread? Urol Int (1986) 0.78
[On the mechanism of action of coronary dilators]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1969) 0.78
Evidence against the adenosine-catecholamine antagonism under in vivo conditions. Naunyn Schmiedebergs Arch Pharmacol (1984) 0.78
[Technique of transurethral electroresection in high-pressure irrigation. Use of a multifunctional irrigation stopcock (author's transl)]. Urol Int (1980) 0.78
Improvement of cardiac preservation by preoperative high insulin supply. J Thorac Cardiovasc Surg (1984) 0.78
The influence of dihydroergotamine on adenosine-induced and reactive coronary vasodilation. Interaction of dihydroergotamine and coronary vasodilation. Basic Res Cardiol (1977) 0.78
Synaptonemal complex protein SYCP3 exists in two isoforms showing different conservation in mammalian evolution. Cytogenet Genome Res (2010) 0.78
Myocardial glucose uptake and breakdown during adenosine-induced vasodilation. Pflugers Arch (1976) 0.78
Theoretical analysis of adenosine release from cardiac tissue as influenced by transport inhibitors. Can J Physiol Pharmacol (1983) 0.78